Theresa Macdissi
Physician Assistant · Council Bluffs, IANPI 1164840617
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,570 of the $6,883 with a category attached, or 80.9%. It is spread thinly across 32 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 302 payments — averaging $22.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Intuitive Surgical$1K
- GSK$513
- Harmony Biosciences LLC$456
- Grifols USA, LLC$389
- Actelion Pharmaceuticals US, Inc.$280
- plus $3K from 26 others
What the payments were for
- Travel & lodging$85212%
- Food & beverage$5,57081%
- Education$4617%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 63 | $1,397 |
| Intuitive Surgical | 4 | $1,006 |
| GSK | 40 | $513 |
| Harmony Biosciences LLC | 39 | $456 |
| Grifols USA, LLC | 13 | $389 |
| Actelion Pharmaceuticals US, Inc. | 11 | $280 |
| Boehringer Ingelheim | 15 | $261 |
| Mallinckrodt Hospital Products Inc. | 6 | $260 |
| Amgen | 11 | $224 |
| Jazz Pharmaceuticals Inc. | 10 | $197 |
| Astellas Pharma US Inc | 6 | $194 |
| Electromed, Inc. | 16 | $189 |
| Sanofi-aventis U.S. LLC | 2 | $172 |
| Avadel CNS Pharmaceuticals, LLC | 8 | $168 |
| Mylan Specialty L.p. | 9 | $167 |
| United Therapeutics Corporation | 7 | $162 |
| Regeneron Healthcare Solutions, Inc. | 9 | $139 |
| Pulmonx Corporation | 2 | $115 |
| Sanofi | 5 | $92 |
| Baxter Healthcare | 4 | $89 |
| Insmed, Inc. | 4 | $67 |
| Merck | 3 | $63 |
| Paratek Pharmaceuticals, Inc. | 3 | $60 |
| Johnson & Johnson | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $21 |
| Bayer | 1 | $19 |
| Philips North America LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Pfizer | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$833
- FASENRA$411
- BREZTRI$287
- Prolastin-C Liquid$125
- TEZSPIRE$124
- AIRSUPRA$124
How this compares
$6,883 in reported general payments places this provider in the 95th percentile of 1,140 physician assistant providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 139 | $102,746 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 50 | $30,460 |
| Breo ElliptaFluticasone/Vilanterol | 50 | $23,317 |
| Spiriva RespimatTiotropium Bromide | 28 | $18,994 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 35 | $18,464 |
| Incruse ElliptaUmeclidinium Bromide | 32 | $11,233 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $8,175 |
| EliquisApixaban | 12 | $7,001 |
| Roflumilast | 31 | $4,268 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 99 | $2,730 |
| Ventolin HfaAlbuterol Sulfate | 15 | $964 |
| Azithromycin | 23 | $217 |
| Methylprednisolone | 25 | $157 |
| Prednisone | 40 | $156 |
| Fluticasone Propionate | 13 | $102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $513 | $155,761256 claims |
| AstraZenecaBreztri Aerosphere | $1,397 | $30,46050 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $261 | $27,16939 claims |
| PfizerEliquis | $17 | $7,00112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,140 physician assistant providers in Iowa.
Other physician assistant in Council Bluffs
- Sara RygolCouncil Bluffs$11K
- Joyce VacekCouncil Bluffs$7K
- Amanda LynnCouncil Bluffs$6K
- Holly BaumannCouncil Bluffs$5K
- Quinn SchulteCouncil Bluffs$5K
- Wendy JohnsonCouncil Bluffs$4K
- Jayson GesulgaUrbandale$878K
- Laurie ClairJohnston$293K
- Katherine LemAmes$224K
- Laura CunninghamWest Des Moines$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.